BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6430368)

  • 1. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
    Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
    Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rhesus antibodies (Anti-Rh0 (D)) in autoimmune thrombocytopenia: correlation with response to high dose IgG and the degree of haemolysis.
    Panzer S; Grümayer ER; Haas OA; Niessner H; Graninger W
    Blut; 1986 Feb; 52(2):117-21. PubMed ID: 3081067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D).
    Becker T; Küenzlen E; Salama A; Mertens R; Kiefel V; Weiss H; Lampert F; Gaedicke G; Mueller-Eckhardt C
    Eur J Pediatr; 1986 Aug; 145(3):166-9. PubMed ID: 3021462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of idiopathic thrombocytopenic purpura and thrombocytopenia associated with the HIV virus using anti-Rhesus immunoglobulins].
    Durand JM; Lefèvre P; Lafforgue P; Harlé JR; Quinsat D; Mongin M
    Presse Med; 1989 Feb; 18(4):161-4. PubMed ID: 2522199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG.
    Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J
    Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous immunoglobulin in immune thrombocytopenia.
    Salama A; Mueller-Eckhardt C; Kiefel V
    Lancet; 1983 Jul; 2(8343):193-5. PubMed ID: 6135031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia.
    Salama A; Kiefel V; Mueller-Eckhardt C
    Am J Hematol; 1986 Jul; 22(3):241-50. PubMed ID: 3087158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
    Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
    Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
    Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
    Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspects.
    Sagripanti A; Ferretti A; Giannessi D; Carpi A; Bernini W; Ambrogi F; De Caterina R
    Biomed Pharmacother; 1998; 52(7-8):293-7. PubMed ID: 9809171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura.
    Oksenhendler E; Bierling P; Brossard Y; Schenmetzler C; Girard PM; Seligmann M; Clauvel JP
    Blood; 1988 May; 71(5):1499-502. PubMed ID: 2833961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia].
    Giers G; Salama A; Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1992 Jan; 117(1):1-5. PubMed ID: 1730192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
    Fehr J; Hofmann V; Kappeler U
    N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura.
    Gringeri A; Cattaneo M; Santagostino E; Mannucci PM
    Br J Haematol; 1992 Mar; 80(3):337-40. PubMed ID: 1581213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet antibody in prolonged remission of childhood idiopathic thrombocytopenic purpura.
    Ware R; Kinney TR; Rosse W
    J Pediatr; 1985 Nov; 107(5):708-11. PubMed ID: 4056968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ITP with immunoglobulin anti-Rh0 (D).
    Colomina P; Cervero A; García S
    Blut; 1989 Sep; 59(3):240. PubMed ID: 2506954
    [No Abstract]   [Full Text] [Related]  

  • 20. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin.
    Smith NA; Chakraverty RK; Boughton BJ
    Clin Lab Haematol; 1990; 12(2):131-6. PubMed ID: 2119931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.